欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SI/H/0223/001
药品名称Azacitidine Onkogen 25 mg/mL Powder for Suspension for Injection
活性成分
    • azacitidine 25.0 mg/ml
剂型Powder for suspension for injection
上市许可持有人Onkogen Kft. 77-79 Becsi rd 1037 Budapest Hungary
参考成员国 - 产品名称Slovenia (SI)
Azacitidin Onkogen 25 mg/ml prašek za suspenzijo za injiciranje
互认成员国 - 产品名称
    • Poland (PL)
      Vidaculem
    • Portugal (PT)
    • Hungary (HU)
    • Czechia (CZ)
      Azacitidine Onkogen 25 mg/mL Powder for Suspension for Injection
    • Italy (IT)
    • Romania (RO)
      Azacitidine Onkogen 25mg/ml powder for suspension for injection
许可日期2021/07/16
最近更新日期2024/03/25
药物ATC编码
    • L01BC07 azacitidine
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase